Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

WASHINGTON (Nexstar) — A U.S. Food and Drug Administration panel on Friday rejected Pfizer’s request to administer a third COVID-19 booster shot to the general public. The independent advisory ...

In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The U.S. Food and Drug Administration has authorized booster shots of the Moderna and Pfizer COVID-19 vaccines for all adults ages 18 and older. On Friday, the FDA announced it had amended the ...